Remibrutinib (Rhapsido) for chronic spontaneous urticaria

Overview of attention for article published in Trends in Pharmacological Sciences, May 2026

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 1 Bluesky post from an account with 203 followers.

Remibrutinib (Rhapsido) for chronic spontaneous urticaria

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.